CANCER AND LEUKEMIA GROUP B

描述(改编自申请人的摘要)：这份拨款申请 是为支持加州医科大学的CALGB计划而提交的 南卡罗来纳州(MUSC)。MUSC自7月起才成为CALGB的主要成员 1995年。然而，已经是小组副主席，CALGB副主席 放射肿瘤学委员会，CALGB呼吸委员会主席， 一名第三阶段礼宾主席和四名研究联合主席是南加州大学的教职员工 参与者。实验治疗学、分子生物学中的主动MUSC计划 肿瘤学和癌症预防与控制涉及研究 以CALGB为基础的临床及相关活动具有直接意义 将在本报告所涵盖的赠款周期内向工作组提出的项目 申请。CALGB试验的应计利润已被指定为最高 机构临床试验优先由癌症中心主任在 南加州大学。拉尔夫·H·约翰逊退伍军人事务部与CALGB建立新的附属关系 截至1997年夏天，查尔斯顿的医疗中心正在建设中。 这将大大有助于增加机构应计利润。 MUSC的少数股东应计利润一直是CALGB平均水平的两倍以上。 从1993年25%的低点(当时MUSC参与 CALGB作为Bowman Gray的附属公司)在1995年增加到36%。MUSC计划 参与作为部分提交的NCI少数民族应计计划 CALGB主席的中央办公室补助金。这一倡议计划和 南加州大学霍林斯癌症中心和查尔斯顿医院之间的新项目 少数族裔社区，在本申请中描述，应该促进其他 少数应计利润。1996年9月在MUSC进行的CALGB审计被评为 太棒了。南卡罗来纳医科大学是一个有效的新 癌症和白血病B组中处于强势地位的主要成员 对…作出重大的科学、管理和应计的贡献 本集团于本拨款申请所涵盖的五年期间内。

DESCRIPTION (adapted from the applicant's abstract): This grant application is submitted in support of the CALGB program at the Medical University of South Carolina (MUSC). MUSC has been a main member of CALGB only since July 1995. Yet already the Group Vice Chair, the Vice Chair of the CALGB Radiation Oncology Committee, the Chair of the CALGB Respiratory Committee, one phase III protocol chair, and four study co-chairs are MUSC faculty participants. Active MUSC programs in Experimental Therapeutics, Molecular Oncology, and Cancer Prevention and Control are involved in research activities of direct significance for CALGB based clinical and correlative projects to be proposed to the Group during the grant cycle covered by this application. Accrual to CALGB trials has been designated as the top institutional clinical trials priority by the Cancer Center Director at MUSC. A new CALGB affiliate relationship for the Ralph H. Johnson VA Medical Center in Charleston is being developed as of the Summer of 1997. This will contribute substantially to increased institutional accrual. Minority accrual at MUSC has always been more than double the CALGB average. It has ranged from a low of 25 percent in 1993 (when MUSC participated in CALGB as a Bowman Gray affiliate) to 36 percent in 1995. MUSC plans to participate in the NCI Minority accrual Initiative Program submitted as part of the CALGB Chairman's Central Office Grant. This initiative program and new programs between the Hollings Cancer Center at MUSC and the Charleston minority community, described in this application, should foster additional minority accrual. A CALGB audit at MUSC in September of 1996 was rated as excellent. The Medical University of South Carolina is an effective new Main Member in the Cancer and Leukemia Group B that is in a strong position to make important scientific, administrative, and accrual contribution to the Group during the five year period covered by this grant request.